Pulmonary artery sarcoma is a rare malignant neoplasm. Here, we describe a patient with a pulmonary artery sarcoma, which was only subtly visible and therefore not fully appreciated on initial transthoracic echocardiogram. Characterization of the tumor was aided by the use of multimodality imaging that included computed tomography, magnetic resonance imaging, and positron emission tomography. Familiarity with its appearance on multiple imaging modalities including echocardiography is important to ensure timely diagnosis, although the optimal treatment strategy is still unknown, and the prognosis remains poor.
K E Y W O R D Scomputed tomography, echocardiography, magnetic resonance imaging, positron emission tomography, pulmonary artery sarcoma A 21-year-old man presented with pleuritic chest pain and dyspnea.Due to an enlarged cardiac silhouette on chest x-ray, a transthoracic echocardiogram (TTE) was performed but was reported to be unremarkable. Subsequent computed tomography (CT) of the chest with contrast revealed a filling defect in the main pulmonary artery (PA) extending into the right PA, along with multiple lung nodules. Despite anticoagulation for a presumed pulmonary embolism, his symptoms worsened. On repeat CT, the filling defect extended into the right PA below the pulmonic valve with no filling defects in the left PA, which was considered atypical for a thrombus ( Figure 1A). Biopsy of the lung nodules revealed sarcoma and magnetic resonance imaging confirmed a pedunculated tumor arising from a pulmonary valve cusp ( Figure 1B).On positron emission tomography, there was moderately intense fludeoxyglucose activity within the filling defect and minimal activity within several lymph nodes ( Figure 1C). As the disease was not curable due to multiple pleural-based metastases, he received palliative chemotherapy (doxorubicin, ifosfamide-mesna) and radiation therapy. Repeat imaging showed a decrease in size of the sarcoma, which was this time appreciated on TTE ( Figures 1D and 2, Movies S1 and S2). Nevertheless, due to ongoing symptoms, he underwent a palliative PA and pulmonic valve resection with homograft reconstruction. The resected tumor was a 5.5-cm, firm, white-tan, cylindrical, pedunculated mass that adhered to the anterior pulmonary valve ( Figure 1E). It was classified as a French Sarcoma Group Grade 3 synovial sarcoma on pathology ( Figure 1F). He thereafter received second-line therapy with the tyrosine kinase inhibitor, pazopanib, followed by oncogenomics-guided third-line therapy with the histone deacetylase inhibitor, vorinostat. Unfortunately, his disease progressed and he died 32 months after his initial presentation.Pulmonary artery sarcoma is a rare malignancy with a poor prognosis. 1 Although prompt recognition and treatment may prolong survival, half of cases are misdiagnosed as pulmonary embolism. 1 Familiarity